555 related articles for article (PubMed ID: 17654493)
21. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM
Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629
[TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells.
Accornero P; Miretti S; Starvaggi Cucuzza L; Martignani E; Baratta M
J Mol Endocrinol; 2010 Feb; 44(2):115-25. PubMed ID: 19850646
[TBL] [Abstract][Full Text] [Related]
23. The EGF receptor activates ERK but not JNK Ras-dependently in basal conditions but ERK and JNK activation pathways are predominantly Ras-independent during cardiomyocyte stretch.
Duquesnes N; Vincent F; Morel E; Lezoualc'h F; Crozatier B
Int J Biochem Cell Biol; 2009 May; 41(5):1173-81. PubMed ID: 19015044
[TBL] [Abstract][Full Text] [Related]
24. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
Mut M; Lule S; Demir O; Kurnaz IA; Vural I
Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
[TBL] [Abstract][Full Text] [Related]
25. EGF-induced cell migration is mediated by ERK and PI3K/AKT pathways in cultured human lens epithelial cells.
Jiang Q; Zhou C; Bi Z; Wan Y
J Ocul Pharmacol Ther; 2006 Apr; 22(2):93-102. PubMed ID: 16722795
[TBL] [Abstract][Full Text] [Related]
26. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
Wang Z; Wang M; Carr BI
J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308
[TBL] [Abstract][Full Text] [Related]
27. Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma.
Liu Y; Poon RT; Shao W; Sun X; Chen H; Kok TW; Fan ST
Cancer Lett; 2007 Apr; 248(1):32-40. PubMed ID: 16837130
[TBL] [Abstract][Full Text] [Related]
28. Sphingosine 1-phosphate induces EGFR expression via Akt/NF-kappaB and ERK/AP-1 pathways in rat vascular smooth muscle cells.
Hsieh HL; Sun CC; Wu CB; Wu CY; Tung WH; Wang HH; Yang CM
J Cell Biochem; 2008 Apr; 103(6):1732-46. PubMed ID: 17902169
[TBL] [Abstract][Full Text] [Related]
29. G protein-coupled receptor agonist-stimulated expression of ATF3/LRF-1 and c-myc and comitogenic effects in hepatocytes do not require EGF receptor transactivation.
Nilssen LS; Odegård J; Thoresen GH; Molven A; Sandnes D; Christoffersen T
J Cell Physiol; 2004 Dec; 201(3):349-58. PubMed ID: 15389557
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer.
Dominguez-Escrig JL; Kelly JD; Neal DE; King SM; Davies BR
Clin Cancer Res; 2004 Jul; 10(14):4874-84. PubMed ID: 15269164
[TBL] [Abstract][Full Text] [Related]
31. EGF‑stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib‑resistant human lung cancer cell line.
Nishimura Y; Takiguchi S; Ito S; Itoh K
Int J Oncol; 2015 Apr; 46(4):1721-9. PubMed ID: 25653196
[TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells.
Song JY; Lee SW; Hong JP; Chang SE; Choe H; Choi J
Cancer Lett; 2009 Oct; 283(2):135-42. PubMed ID: 19380191
[TBL] [Abstract][Full Text] [Related]
33. Essential role for G proteins in prostate cancer cell growth and signaling.
Kue PF; Daaka Y
J Urol; 2000 Dec; 164(6):2162-7. PubMed ID: 11061948
[TBL] [Abstract][Full Text] [Related]
34. Heparin suppresses lipid raft-mediated signaling and ligand-independent EGF receptor activation.
Liu YT; Song L; Templeton DM
J Cell Physiol; 2007 Apr; 211(1):205-12. PubMed ID: 17226785
[TBL] [Abstract][Full Text] [Related]
35. Altered regulation of EGF receptor signaling following a partial hepatectomy.
Skarpen E; Oksvold MP; Grøsvik H; Widnes C; Huitfeldt HS
J Cell Physiol; 2005 Mar; 202(3):707-16. PubMed ID: 15389569
[TBL] [Abstract][Full Text] [Related]
36. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival.
Coutant A; Rescan C; Gilot D; Loyer P; Guguen-Guillouzo C; Baffet G
Hepatology; 2002 Nov; 36(5):1079-88. PubMed ID: 12395317
[TBL] [Abstract][Full Text] [Related]
37. Role of ErbB2 in the prostaglandin E₂-induced enhancement of the mitogenic response to epidermal growth factor in cultured hepatocytes.
Ødegård J; Aasrum M; Tveteraas IH; Bharath SP; Sandnes D; Christoffersen T
Biochem Biophys Res Commun; 2012 May; 421(2):255-60. PubMed ID: 22503980
[TBL] [Abstract][Full Text] [Related]
38. Additive and inhibitory effects of simultaneous treatment with growth factors on DNA synthesis through MAPK pathway and G1 cyclins in rat hepatocytes.
Moriuchi A; Hirono S; Ido A; Ochiai T; Nakama T; Uto H; Hori T; Hayashi K; Tsubouchi H
Biochem Biophys Res Commun; 2001 Jan; 280(1):368-73. PubMed ID: 11162525
[TBL] [Abstract][Full Text] [Related]
39. Endosomal signalling of epidermal growth factor receptors contributes to EGF-stimulated cell cycle progression in primary hepatocytes.
Luo Y; Cheng Z; Dixon CJ; Hall JF; Taylor E; Boarder MR
Eur J Pharmacol; 2011 Mar; 654(2):173-80. PubMed ID: 21172338
[TBL] [Abstract][Full Text] [Related]
40. Stearoyl-CoA desaturase activity modulates the activation of epidermal growth factor receptor in human lung cancer cells.
Nashed M; Chisholm JW; Igal RA
Exp Biol Med (Maywood); 2012 Sep; 237(9):1007-17. PubMed ID: 22946088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
